Active Ingredient: TERCONAZOLE
Proprietary Name: TERCONAZOLE
Dosage Form; Route of Administration: SUPPOSITORY; VAGINAL
Strength: 80MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A077149
Product Number: 001
Approval Date: Mar 17, 2006
Applicant Holder Full Name: PADAGIS ISRAEL PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
